Hepatitis B-related membranous nephropathy should be treated with a specific anti-viral agent.
Tang
S
S
Lai
K N
KN
D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D024882:Drug Resistance, Viral; D015433:Glomerulonephritis, Membranous / Q000188:drug therapy* / Q000821:virology*; D006509:Hepatitis B / Q000151:congenital / Q000188:drug therapy*; D006515:Hepatitis B virus; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology / Q000627:therapeutic use*; D012074:Remission Induction / Q000379:methods; D055502:Secondary Prevention; D013997:Time Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D019259:Lamivudine